Amneal Pharmaceuticals, Inc. (AMRX)
12.60
-0.28
(-2.17%)
USD |
NASDAQ |
Dec 31, 16:00
12.51
-0.09
(-0.71%)
After-Hours: 20:00
Amneal Pharmaceuticals Market Cap: 3.961B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 498.60B |
| Amgen, Inc. | 176.25B |
| Corcept Therapeutics, Inc. | 3.661B |
| United Therapeutics Corp. | 20.98B |
| Xeris Biopharma Holdings, Inc. | 1.303B |
Market Cap Related Metrics
| PE Ratio | 893.62 |
| PS Ratio | 1.375 |
| Price to Free Cash Flow | 17.07 |
| Price | 12.60 |
| Earnings Yield | 0.11% |
| Operating PE Ratio | 11.08 |
| Normalized PE Ratio | 117.21 |